Investing.com - Xtant Medical (NYSE: XTNT) reported first quarter EPS of $-0.0300, worse than the analyst estimate of $-0.0253. Revenue for the quarter came in at $28.11M versus the consensus estimate of $26.54M.
Xtant Medical's stock price closed at $1.17. It is down -8.5900% in the last 3 months and up 70.9800% in the last 12 months.
Xtant Medical saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Xtant Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Xtant Medical's Financial Health score is "good performance".
Check out Xtant Medical's recent earnings performance, and Xtant Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar